(HealthDay)—Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older, the U.S. Food and Drug Administration announced yesterday. Approved to treat type 2 ...

Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the skin.

Victoza is not FDA-approved for weight loss. If your doctor prescribes Victoza for weight management or weight loss, that’s ...

As with other drugs, Victoza (liraglutide) injections can cause side effects, such as nausea, diarrhea, and decreased appetite. If side effects of Victoza become difficult to tolerate, talk with your ...

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes and lower the risk of cardiovascular problems in certain people. Mild side effects of the drug include nausea, diarrhea, and ...

Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...

Victoza (liraglutide) and Ozempic (semaglutide) are brand-name subcutaneous injections. They’re both prescribed for people with type 2 diabetes. Victoza and Ozempic belong to the same drug class ...

Both Victoza and Ozempic can help reduce the risk of heart attack and stroke in people with type 2 diabetes. Victoza is ...

In a global move, Indian pharmaceutical company, Lupin on Friday has launched a generic diabetes medication in the US market. It has launched Liraglutide Injection, 18 mg/3 mL (6 mg/mL) single-patient ...

If you're looking into weight loss drugs, liraglutide has no doubt popped up. It's a diabetes and weight loss medication sold under the brand names Victoza and Saxenda. Read on for everything you need ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...